In this episode, we delve into the science and story behind Peptinovo Biopharma, a biotech startup developing a lipid-mimicking nanotechnology platform that could revolutionize the delivery of chemotherapy. Instead of inventing new drugs, Peptinovo is redesigning how trusted ones, such as paclitaxel, reach their targets, aiming for fewer side effects and better outcomes.

Now raising via Reg CF, Peptinovo invites retail investors to support the next chapter of clinical development. We break down the science, market opportunity, and risks in plain English.

🧾 Disclaimer: This episode is for informational purposes only. Invst Guru is not affiliated with Peptinovo Biopharma, the offering platform, or any broker-dealer. This is not investment advice or a solicitation to invest. All investment activity under Regulation Crowdfunding must occur via a registered funding portal. To learn more, visit the company’s offering page at https://hi.switchy.io/PeptinovoJULY25.

Hosted on Acast. See acast.com/privacy for more information.

In this episode of The Invst Guru Spotlight, we explore the behavioral science behind Qube Money — a fintech platform built to enforce intentional spending at the moment of purchase. Unlike traditional budgeting apps that analyze past behavior, Qube takes a real-time approach using patented transaction-level authorization.

Join us as we explore how Qube's envelope-style budgeting model operates, why retention metrics indicate significant user engagement, and how the company is positioning itself in a competitive fintech market. We also discuss their active Regulation Crowdfunding campaign on StartEngine, the risks associated with early-stage investments, and what sets Qube apart from other neobanks.

🚨 Regulation Crowdfunding Disclaimer:

This episode mentions a company currently raising capital under Regulation Crowdfunding (Reg CF). No investment terms are provided in this podcast. All investments must be made through the official intermediary platform. Please visit Qube’s campaign page on StartEngine to review offering documents, risks, and disclosures before making any investment decisions.

Hosted on Acast. See acast.com/privacy for more information.

Doctors are often perceived as high earners, but few realize the financial challenges they face early in their careers, including crushing student debt, limited credit histories, and inflexible loan terms. In this episode, we sit down with Doc2Doc Lending co-founder Dr. Zwade Marshall to unpack how he and his team built a lending platform designed specifically for physicians.

We explore:

• The systemic bias in traditional underwriting models
• Why financial stress is contributing to physician burnout
• How Doc2Doc uses physician-specific data to make smarter lending decisions
• Their 30% YoY growth trajectory — and what it means for investors
• Why they chose Reg CF and what this crowdfunding raise could unlock

Whether you're in healthcare, fintech, or just fascinated by founder stories that solve real problems, this one goes deep.

Hosted on Acast. See acast.com/privacy for more information.